Stereotaxis, Inc. (STXS) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
STXS Revenue Growth
Revenue Breakdown (FY 2024)
STXS's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
STXS Revenue Analysis (2013–2024)
As of May 8, 2026, Stereotaxis, Inc. (STXS) generated trailing twelve-month (TTM) revenue of $30.1 million, reflecting significant decline in growth of -18.8% year-over-year. The most recent quarter (Q3 2025) recorded $7.5 million in revenue, down 15.2% sequentially.
Looking at the longer-term picture, STXS's 5-year compound annual growth rate (CAGR) stands at -1.4%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $38.0 million in 2013.
Revenue diversification analysis shows STXS's business is primarily driven by Disposables, service and accessories (68%), and Systems (32%). With over half of revenue concentrated in Disposables, service and accessories, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ISRG (+21.4% YoY), NVCR (+8.5% YoY), and ABT (+6.4% YoY), STXS has underperformed the peer group in terms of revenue growth. Compare STXS vs ISRG →
STXS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| STXSCurrent | $30M | -18.8% | -1.4% | -91.9% | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% |
STXS Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $26.9M | +0.5% | $14.6M | 54.2% | $-24,739,000 | -91.9% |
| 2023 | $26.8M | -4.9% | $14.9M | 55.5% | $-21,839,000 | -81.6% |
| 2022 | $28.1M | -19.6% | $18.5M | 65.6% | $-18,776,000 | -66.7% |
| 2021 | $35.0M | +31.5% | $23.2M | 66.3% | $-12,888,000 | -36.8% |
| 2020 | $26.6M | -7.9% | $19.0M | 71.2% | $-6,713,815 | -25.2% |
| 2019 | $28.9M | -1.5% | $22.8M | 78.8% | $-4,826,859 | -16.7% |
| 2018 | $29.3M | -5.8% | $23.6M | 80.5% | $-2,457,039 | -8.4% |
| 2017 | $31.1M | -3.2% | $20.4M | 65.5% | $-5,919,597 | -19.0% |
| 2016 | $32.2M | -14.6% | $24.6M | 76.6% | $-6,426,357 | -20.0% |
| 2015 | $37.7M | +7.6% | $27.2M | 72.3% | $-5,410,528 | -14.4% |
See STXS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs STXS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare STXS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSTXS — Frequently Asked Questions
Quick answers to the most common questions about buying STXS stock.
Is STXS's revenue growth accelerating or slowing?
STXS revenue declined -18.8% year-over-year, contrasting with the 5-year CAGR of -1.4%. TTM revenue fell to $30M. This reverses the prior growth trend.
What is STXS's long-term revenue growth rate?
Stereotaxis, Inc.'s 5-year revenue CAGR of -1.4% reflects the variable expansion pattern. Current YoY growth of -18.8% is below this long-term average.
How is STXS's revenue distributed by segment?
STXS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.